Tapewire

NYSE · USD

TDOC

Teladoc Health, Inc.

Export transactions ↓
Tapewire entity
1547
SEC CIK
0001477449
Parsed reports
839

Last 12 months

Inside the activity.

1 purchase rows · 37 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202510
Dec 202506
Jan 202601
Feb 202600
Mar 202608
Apr 202601
May 202600
Jun 202609
Jul 202603
Aug 202600
Sep 202608
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
July 17, 2020 Filed Jul 20, 2020 20:09 UTC Exercise / conversionCommon Stock 740 $6.01 $4,447.40
Disclosure

SEC source: 0001179110-20-008374 · edgar.xml · nonDerivative · entry 1

Frist William H. · CIK 0001477553 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,158

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 16, 2020 Filed Jul 20, 2020 20:09 UTC
Levy LewisChief Medical Officer
SaleCommon Stock 4,106 $219.06 $899,460.36
Disclosure

SEC source: 0001179110-20-008373 · edgar.xml · nonDerivative · entry 1

Levy Lewis · CIK 0001726568 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,766

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 13, 2020.

Read SEC document
July 15, 2020 Filed Jul 16, 2020 20:21 UTC
Levy LewisChief Medical Officer
Exercise / conversionRestricted Stock Units · Derivative 7,353 $0.00 $0.00
Disclosure

SEC source: 0001179110-20-008283 · edgar.xml · derivative · entry 3

Levy Lewis · CIK 0001726568 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,353

Underlying: Common Stock · 7,353 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.

F4 · derivative.exercise_date: On July 14, 2017, the reporting person was was granted 29,412 restricted stock units, vesting in four equal annual installments beginning on July 14, 2018.

F4 · derivative.expiration_date: On July 14, 2017, the reporting person was was granted 29,412 restricted stock units, vesting in four equal annual installments beginning on July 14, 2018.

Read SEC document
July 15, 2020 Filed Jul 16, 2020 20:21 UTC
Levy LewisChief Medical Officer
SaleCommon Stock 3,247 $210.14 $682,324.58
Disclosure

SEC source: 0001179110-20-008283 · edgar.xml · nonDerivative · entry 2

Levy Lewis · CIK 0001726568 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,872

F2 · shares: Shares sold to cover the issuer's withholding obligation in respect of reporting person's award.

Read SEC document
July 15, 2020 Filed Jul 16, 2020 20:21 UTC
Levy LewisChief Medical Officer
Exercise / conversionCommon Stock 7,353 Not disclosed Not disclosed
Disclosure

SEC source: 0001179110-20-008283 · edgar.xml · nonDerivative · entry 1

Levy Lewis · CIK 0001726568 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,119

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

Read SEC document
July 10, 2020 Filed Jul 13, 2020 20:17 UTC Exercise / conversionStock Option (right to buy) · Derivative 740 $0.00 Strike: $6.01 $0.00
Disclosure

SEC source: 0001179110-20-008242 · edgar.xml · derivative · entry 3

Frist William H. · CIK 0001477553 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,490

Underlying: Common Stock · 740 shares

Expires 2024-09-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vested as to 25% of the shares on September 10, 2015. The remainder of the shares vested in 36 equal monthly installments thereafter.

Read SEC document
July 10, 2020 Filed Jul 13, 2020 20:17 UTC SaleCommon Stock 740 $228.00 $168,720.00
Disclosure

SEC source: 0001179110-20-008242 · edgar.xml · nonDerivative · entry 2

Frist William H. · CIK 0001477553 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,418

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 6, 2020.

Read SEC document
July 10, 2020 Filed Jul 13, 2020 20:17 UTC Exercise / conversionCommon Stock 740 $6.01 $4,447.40
Disclosure

SEC source: 0001179110-20-008242 · edgar.xml · nonDerivative · entry 1

Frist William H. · CIK 0001477553 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,158

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 08, 2020 Filed Jul 10, 2020 17:15 UTC
Turitz AndrewSVP - Business Development
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 5,017 $0.00 Strike: $38.55 $0.00
Disclosure

SEC source: 0001179110-20-008171 · edgar.xml · derivative · entry 3

Turitz Andrew · CIK 0001726221 · SVP - Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,333

Underlying: Common Stock · 5,017 shares

Expires 2028-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vested as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter.

Read SEC document
July 08, 2020 Filed Jul 10, 2020 17:15 UTC
Turitz AndrewSVP - Business Development
SaleCommon Stock 5,017 $225.00 $1,128,825.00
Disclosure

SEC source: 0001179110-20-008171 · edgar.xml · nonDerivative · entry 2

Turitz Andrew · CIK 0001726221 · SVP - Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,015

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 3, 2020.

Read SEC document
July 08, 2020 Filed Jul 10, 2020 17:15 UTC
Turitz AndrewSVP - Business Development
Exercise / conversionCommon Stock 5,017 $38.55 $193,405.35
Disclosure

SEC source: 0001179110-20-008171 · edgar.xml · nonDerivative · entry 1

Turitz Andrew · CIK 0001726221 · SVP - Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,032

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 07, 2020 Filed Jul 8, 2020 20:02 UTC Exercise / conversionStock Option (right to buy) · Derivative 10,000 $0.00 Strike: $6.01 $0.00
Disclosure

SEC source: 0001179110-20-008105 · edgar.xml · derivative · entry 6

Frist William H. · CIK 0001477553 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,230

Underlying: Common Stock · 10,000 shares

Expires 2024-09-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vested as to 25% of the shares on September 10, 2015. The remainder of the shares vested in 36 equal monthly installments thereafter.

Read SEC document
July 07, 2020 Filed Jul 8, 2020 20:02 UTC SaleCommon Stock 10,000 $220.00 $2,200,000.00
Disclosure

SEC source: 0001179110-20-008105 · edgar.xml · nonDerivative · entry 4

Frist William H. · CIK 0001477553 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,418

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 6, 2020.

Read SEC document
July 07, 2020 Filed Jul 8, 2020 20:02 UTC Exercise / conversionCommon Stock 10,000 $6.01 $60,100.00
Disclosure

SEC source: 0001179110-20-008105 · edgar.xml · nonDerivative · entry 3

Frist William H. · CIK 0001477553 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,418

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 07, 2020 Filed Jul 10, 2020 21:15 UTC
Gorevic Jason NDirector · Chief Executive Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 30,000 $0.00 Strike: $6.01 $0.00
Disclosure

SEC source: 0001179110-20-008170 · edgar.xml · derivative · entry 3

GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,310

Underlying: Common Stock · 30,000 shares

Expires 2024-12-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option vested as to 25% of the shares on December 22, 2015. The remainder of the shares vested or will vest in 36 equal monthly installments thereafter.

Read SEC document
July 07, 2020 Filed Jul 10, 2020 21:15 UTC
Gorevic Jason NDirector · Chief Executive Officer
SaleCommon Stock 30,000 $218.71 $6,561,300.00
Disclosure

SEC source: 0001179110-20-008170 · edgar.xml · nonDerivative · entry 2

GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 667,283

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2020.

F2 · price: Represents the weighted average price of transactions ranging from $214.64 to $223.57. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
July 07, 2020 Filed Jul 10, 2020 21:15 UTC
Gorevic Jason NDirector · Chief Executive Officer
Exercise / conversionCommon Stock 30,000 $6.01 $180,300.00
Disclosure

SEC source: 0001179110-20-008170 · edgar.xml · nonDerivative · entry 1

GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 697,283

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 06, 2020 Filed Jul 8, 2020 16:02 UTC
Turitz AndrewSVP - Business Development
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 1,389 $0.00 Strike: $22.30 $0.00
Disclosure

SEC source: 0001179110-20-008106 · edgar.xml · derivative · entry 3

Turitz Andrew · CIK 0001726221 · SVP - Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,113

Underlying: Common Stock · 1,389 shares

Expires 2027-03-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vested as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter.

Read SEC document
July 06, 2020 Filed Jul 8, 2020 16:02 UTC
Turitz AndrewSVP - Business Development
SaleCommon Stock 1,389 $212.37 $294,981.93
Disclosure

SEC source: 0001179110-20-008106 · edgar.xml · nonDerivative · entry 2

Turitz Andrew · CIK 0001726221 · SVP - Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,015

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 3, 2020.

Read SEC document
July 06, 2020 Filed Jul 8, 2020 16:02 UTC
Turitz AndrewSVP - Business Development
Exercise / conversionCommon Stock 1,389 $22.30 $30,974.70
Disclosure

SEC source: 0001179110-20-008106 · edgar.xml · nonDerivative · entry 1

Turitz Andrew · CIK 0001726221 · SVP - Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,404

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 06, 2020 Filed Jul 8, 2020 20:05 UTC
Vandervoort Adam CChief Legal Officer, Secretary
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 1,164 $0.00 Strike: $38.55 $0.00
Disclosure

SEC source: 0001179110-20-008107 · edgar.xml · derivative · entry 5

Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,292

Underlying: Common Stock · 1,164 shares

Expires 2028-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option vested as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter.

Read SEC document
July 06, 2020 Filed Jul 8, 2020 20:05 UTC
Vandervoort Adam CChief Legal Officer, Secretary
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 1,447 $0.00 Strike: $22.30 $0.00
Disclosure

SEC source: 0001179110-20-008107 · edgar.xml · derivative · entry 4

Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,574

Underlying: Common Stock · 1,447 shares

Expires 2027-03-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vested as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter.

Read SEC document
July 06, 2020 Filed Jul 8, 2020 20:05 UTC
Vandervoort Adam CChief Legal Officer, Secretary
SaleCommon Stock 2,611 $212.37 $554,498.07
Disclosure

SEC source: 0001179110-20-008107 · edgar.xml · nonDerivative · entry 3

Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 16, 2020.

Read SEC document
July 06, 2020 Filed Jul 8, 2020 20:05 UTC
Vandervoort Adam CChief Legal Officer, Secretary
Exercise / conversionCommon Stock 1,164 $38.55 $44,872.20
Disclosure

SEC source: 0001179110-20-008107 · edgar.xml · nonDerivative · entry 2

Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,811

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 06, 2020 Filed Jul 8, 2020 20:05 UTC
Vandervoort Adam CChief Legal Officer, Secretary
Exercise / conversionCommon Stock 1,447 $22.30 $32,268.10
Disclosure

SEC source: 0001179110-20-008107 · edgar.xml · nonDerivative · entry 1

Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,647

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 06, 2020 Filed Jul 8, 2020 20:02 UTC Exercise / conversionStock Option (right to buy) · Derivative 740 $0.00 Strike: $6.01 $0.00
Disclosure

SEC source: 0001179110-20-008105 · edgar.xml · derivative · entry 5

Frist William H. · CIK 0001477553 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,230

Underlying: Common Stock · 740 shares

Expires 2024-09-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vested as to 25% of the shares on September 10, 2015. The remainder of the shares vested in 36 equal monthly installments thereafter.

Read SEC document
July 06, 2020 Filed Jul 8, 2020 20:02 UTC SaleCommon Stock 740 $212.37 $157,153.80
Disclosure

SEC source: 0001179110-20-008105 · edgar.xml · nonDerivative · entry 2

Frist William H. · CIK 0001477553 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,418

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 6, 2020.

Read SEC document
July 06, 2020 Filed Jul 8, 2020 20:02 UTC Exercise / conversionCommon Stock 740 $6.01 $4,447.40
Disclosure

SEC source: 0001179110-20-008105 · edgar.xml · nonDerivative · entry 1

Frist William H. · CIK 0001477553 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,158

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 02, 2020 Filed Jul 6, 2020 16:06 UTC
Verstraete StephanyChief Marketing Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 2,000 $0.00 Strike: $22.30 $0.00
Disclosure

SEC source: 0001179110-20-008014 · edgar.xml · derivative · entry 3

Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,600

Underlying: Common Stock · 2,000 shares

Expires 2027-03-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vested as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter.

Read SEC document
July 02, 2020 Filed Jul 6, 2020 16:06 UTC
Verstraete StephanyChief Marketing Officer
SaleCommon Stock 2,000 $204.00 $408,000.00
Disclosure

SEC source: 0001179110-20-008014 · edgar.xml · nonDerivative · entry 2

Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,276

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 4, 2020.

Read SEC document
July 02, 2020 Filed Jul 6, 2020 16:06 UTC
Verstraete StephanyChief Marketing Officer
Exercise / conversionCommon Stock 2,000 $22.30 $44,600.00
Disclosure

SEC source: 0001179110-20-008014 · edgar.xml · nonDerivative · entry 1

Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,276

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 02, 2020 Filed Jul 6, 2020 20:05 UTC Exercise / conversionStock Option (right to buy) · Derivative 10,000 $0.00 Strike: $6.01 $0.00
Disclosure

SEC source: 0001179110-20-008013 · edgar.xml · derivative · entry 3

Frist William H. · CIK 0001477553 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,970

Underlying: Common Stock · 10,000 shares

Expires 2024-09-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vested as to 25% of the shares on September 10, 2015. The remainder of the shares vested in 36 equal monthly installments thereafter.

Read SEC document
July 02, 2020 Filed Jul 6, 2020 20:05 UTC SaleCommon Stock 10,000 $210.00 $2,100,000.00
Disclosure

SEC source: 0001179110-20-008013 · edgar.xml · nonDerivative · entry 2

Frist William H. · CIK 0001477553 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,418

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 6, 2020.

Read SEC document
July 02, 2020 Filed Jul 6, 2020 20:05 UTC Exercise / conversionCommon Stock 10,000 $6.01 $60,100.00
Disclosure

SEC source: 0001179110-20-008013 · edgar.xml · nonDerivative · entry 1

Frist William H. · CIK 0001477553 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,418

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 01, 2020 Filed Jul 2, 2020 16:01 UTC
Verstraete StephanyChief Marketing Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 4,000 $0.00 Strike: $22.30 $0.00
Disclosure

SEC source: 0001179110-20-007937 · edgar.xml · derivative · entry 4

Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,600

Underlying: Common Stock · 4,000 shares

Expires 2027-03-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vested as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter.

Read SEC document
July 01, 2020 Filed Jul 2, 2020 16:01 UTC
Verstraete StephanyChief Marketing Officer
SaleCommon Stock 2,000 $190.00 $380,000.00
Disclosure

SEC source: 0001179110-20-007937 · edgar.xml · nonDerivative · entry 3

Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,276

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 4, 2020.

Read SEC document
July 01, 2020 Filed Jul 2, 2020 16:01 UTC
Verstraete StephanyChief Marketing Officer
SaleCommon Stock 2,000 $189.90 $379,800.00
Disclosure

SEC source: 0001179110-20-007937 · edgar.xml · nonDerivative · entry 2

Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,276

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 4, 2020.

Read SEC document
July 01, 2020 Filed Jul 2, 2020 16:01 UTC
Verstraete StephanyChief Marketing Officer
Exercise / conversionCommon Stock 4,000 $22.30 $89,200.00
Disclosure

SEC source: 0001179110-20-007937 · edgar.xml · nonDerivative · entry 1

Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,276

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 01, 2020 Filed Jul 2, 2020 20:00 UTC
Levy LewisChief Medical Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 1,275 $0.00 Strike: $38.55 $0.00
Disclosure

SEC source: 0001179110-20-007935 · edgar.xml · derivative · entry 5

Levy Lewis · CIK 0001726568 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,264

Underlying: Common Stock · 1,275 shares

Expires 2028-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option vests as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter.

Read SEC document
July 01, 2020 Filed Jul 2, 2020 20:00 UTC
Levy LewisChief Medical Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 1,395 $0.00 Strike: $35.45 $0.00
Disclosure

SEC source: 0001179110-20-007935 · edgar.xml · derivative · entry 4

Levy Lewis · CIK 0001726568 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,648

Underlying: Common Stock · 1,395 shares

Expires 2027-07-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vests as to 25% of the shares on July 14, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter.

Read SEC document
July 01, 2020 Filed Jul 2, 2020 20:00 UTC
Levy LewisChief Medical Officer
SaleCommon Stock 2,670 $189.90 $507,033.00
Disclosure

SEC source: 0001179110-20-007935 · edgar.xml · nonDerivative · entry 3

Levy Lewis · CIK 0001726568 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,766

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 13, 2020.

Read SEC document
July 01, 2020 Filed Jul 2, 2020 20:00 UTC
Levy LewisChief Medical Officer
Exercise / conversionCommon Stock 1,275 $38.55 $49,151.25
Disclosure

SEC source: 0001179110-20-007935 · edgar.xml · nonDerivative · entry 2

Levy Lewis · CIK 0001726568 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,436

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 01, 2020 Filed Jul 2, 2020 20:00 UTC
Levy LewisChief Medical Officer
Exercise / conversionCommon Stock 1,395 $35.45 $49,452.75
Disclosure

SEC source: 0001179110-20-007935 · edgar.xml · nonDerivative · entry 1

Levy Lewis · CIK 0001726568 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,161

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 01, 2020 Filed Jul 10, 2020 21:16 UTC
Caridi ChristopherChief Accounting Officer
GrantRestricted Stock Units · Derivative 1,274 $0.00 $0.00
Disclosure

SEC source: 0001179110-20-008172 · edgar.xml · derivative · entry 2

Caridi Christopher · CIK 0001700392 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,274

Underlying: Common Stock · 1,274 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.

F2 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning July 1, 2021.

F2 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning July 1, 2021.

Read SEC document
July 01, 2020 Filed Jul 10, 2020 21:16 UTC
Caridi ChristopherChief Accounting Officer
GrantEmployee Stock Option (right to buy) · Derivative 1,796 $0.00 Strike: $198.85 $0.00
Disclosure

SEC source: 0001179110-20-008172 · edgar.xml · derivative · entry 1

Caridi Christopher · CIK 0001700392 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,796

Underlying: Common Stock · 1,796 shares

Expires 2030-07-01

F1 · derivative.exercise_date: The option vests as to 25% of the shares on July 1, 2021. The remainder of the shares vest in 36 equal monthly installments thereafter.

Read SEC document
June 26, 2020 Filed Jul 1, 2020 00:18 UTC Exercise / conversionStock Option (right to buy) · Derivative 740 $0.00 Strike: $6.01 $0.00
Disclosure

SEC source: 0001104659-20-079233 · a4.xml · derivative · entry 3

Frist William H. · CIK 0001477553 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,970

Underlying: Common Stock · 740 shares

Expires 2024-09-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vested as to 25% of the shares on September 10, 2015. The remainder of the shares vested in 36 equal monthly installments thereafter.

Read SEC document
June 26, 2020 Filed Jul 1, 2020 00:18 UTC SaleCommon Stock 740 $203.06 $150,264.40
Disclosure

SEC source: 0001104659-20-079233 · a4.xml · nonDerivative · entry 2

Frist William H. · CIK 0001477553 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,418

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 6, 2020.

Read SEC document
June 26, 2020 Filed Jul 1, 2020 00:18 UTC Exercise / conversionCommon Stock 740 $6.01 $4,447.40
Disclosure

SEC source: 0001104659-20-079233 · a4.xml · nonDerivative · entry 1

Frist William H. · CIK 0001477553 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,158

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 25, 2020 Filed Jun 26, 2020 20:02 UTC
Murthy MalaChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 7,968 $0.00 $0.00
Disclosure

SEC source: 0001179110-20-007788 · edgar.xml · derivative · entry 3

Murthy Mala · CIK 0001780955 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,936

Underlying: Common Stock · 7,968 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.

F4 · derivative.exercise_date: On June 24, 2019, the reporting person was granted 31,872 restricted stock units, vesting as to 25% of the shares on February 20, 2020 with the remainder of the shares vesting in three equal annual installments beginning on the first anniversary of the grant date.

F4 · derivative.expiration_date: On June 24, 2019, the reporting person was granted 31,872 restricted stock units, vesting as to 25% of the shares on February 20, 2020 with the remainder of the shares vesting in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
June 25, 2020 Filed Jun 26, 2020 20:02 UTC
Murthy MalaChief Financial Officer
SaleCommon Stock 3,885 $197.92 $768,919.20
Disclosure

SEC source: 0001179110-20-007788 · edgar.xml · nonDerivative · entry 2

Murthy Mala · CIK 0001780955 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,084

F2 · shares: Shares sold to cover the issuer's withholding obligation in respect of reporting person's award.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.